The transcription factor nuclear factor kappa B (NF-kappa B) is moving to t
he forefront of the fields of apoptosis and neuronal plasticity because of
recent findings showing that activation of NF-kappa B prevents neuronal apo
ptosis in various cell culture and in vivo models and because NF-kappa B is
activated in association with synaptic plasticity. Activation of NF-kappa
B was first shown to mediate antiapoptotic actions of tumor necrosis factor
in cultured neurons and was subsequently shown to prevent death of various
nonneuronal cells. NF-kappa B is activated by several cytokines and neurot
rophic factors and in response to various cell stressors, Oxidative stress
and elevation of intracellular Calcium levels are particularly important in
ducers of NF-kappa B activation, Activation of NF-kappa B can interrupt apo
ptotic biochemical cascades at relatively early steps, before mitochondrial
dysfunction acid oxyradical production; Gene targets for NF-kappa B that m
ay mediate its antiapoptotic actions include the antioxidant enzyme mangane
se superoxide dismutase, members of the inhibitor of apoptosis family of pr
oteins, and the calcium-binding protein calbindin D28k. NF-kappa B is activ
ated by synaptic activity and may play important roles in the process of le
arning and memory. The available data identify NF-kappa B as an important r
egulator of evolutionarily conserved biochemical and molecular cascades des
igned to prevent cell death and promote neuronal plasticity. Because NF-kap
pa B may play roles in a range of neurological disorders that involve neuro
nal degeneration and/or perturbed synaptic function, pharmacological and ge
netic manipulations of NF-kappa B signaling are being developed that may pr
ove valuable in treating disorders ranging from Alzheimer's disease to schi
zophrenia.